Here is the latest stock price and chart of Biocon. For more details, see the Biocon company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
EXPIRES at 11:59pm: Full Transcript of Our Urgent Broadcast on India's Revival
Live BSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)406.50 | Open (Rs) 415.00 | High (Rs) 415.00 | Low (Rs) 399.70 |
% Change-1.53 | Volume 150,404 | Value (Rs) 60,947,105 | 52-Week H/L 487.70 / 320.90 |
Live NSE Quotes | Apr 19, 2021 (Close) | ||
---|---|---|---|
Price (Rs)406.35 | Open (Rs) 412.85 | High (Rs) 412.85 | Low (Rs) 399.75 |
% Change-1.57 | Volume 4,445,076 | Value (Rs) 1,801,567,152 | 52-Week H/L 487.75 / 320.70 |
Change | |||||
---|---|---|---|---|---|
1 Day -1.53% | 1 Month 2.69% | 3 Months -10.01% | 1 Year 13.60% | 5 Years (CAGR)* 33.89% | 10 Years (CAGR)* 21.00% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 12.11 | P/E Ratio (x) 33.56 | Market Cap (Rs m) 243,900.00 | P/BV (x) 4.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
BIOCON last traded price was down 1.5% to Rs 406.5 on the BSE. On the NSE, BIOCON last traded price was down 1.6% to Rs 406.4. The total volume of shares traded was 4.6 m.
Overall, the broader S&P BSE HEALTHCARE Index was up by 0.4%. And the benchmark S&P BSE SENSEX was at 47,949.4 (down 1.8%).
Over the last 30 days, the BIOCON share price is up 3.5%. And over the last one year, BIOCON share price is up 16.2%.
What else is happening in the markets today? Dig in...
Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.
For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More